NL-OMON44983CompletedNot Applicable
Multifocal motor neuropathy: a study on immunological mechanisms and natural history - MAIN study
niversitair Medisch Centrum0 sites320 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 320
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients are subjects who fullfil the diagnostic consensus criteria for MMN (see protocol, page 40)
- •Controls are people who visit the neuromuscular outpatient clinic for diseases other than MMN.
- •All subjects are older than 18 year, are not mentally incapacitated and fully understand the given information for the study
Exclusion Criteria
- •An MMN patient who meets any of the following criteria will be excluded from participation in this study:
- •- Doubts about the diagnosis MMN
- •- Relevant concomitant illnesses (i.e. haematological or immunological diseases) that may interfere with any part of the study
- •A control will be excluded when any of the following criteria is met:
- •- having MMN as a diagnosis in the history
- •- under 18 years old.
- •- not capable of understanding the given information or giving consent.
Investigators
Similar Trials
Withdrawn
Not Applicable
Multifocal motor neuropathy: a natural history study on prognosis, disease mechanism and new biomarkers.Nerve inflammation by own immune systemperiferal motor neuropathy10034606NL-OMON40136niversitair Medisch Centrum Utrecht270
Completed
Not Applicable
Sensory axons in multifocal motor neuropathy (MMN)multifocal motor neuropathy (MMN). This term is familiar to all MMN patients.10034606NL-OMON42685niversitair Medisch Centrum Utrecht20
Completed
Not Applicable
Predictive Factors of Long Term Outcome in MMNMMNNCT04015934Central Hospital, Nancy, France54
Completed
Phase 3
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.Multifocal Motor NeuropathyNCT01827072Nihon Pharmaceutical Co., Ltd13
Active, not recruiting
Phase 1
MND-SMARTMotor Neurone DiseaseMedDRA version: 20.0Level: LLTClassification code 10028002Term: Motor neuron diseaseSystem Organ Class: 100000004852EUCTR2019-000099-41-GBniversity of Edinburgh750